Update on treatment advances in combined-modality therapy for anal and rectal carcinomas

Jeffrey Meyer, Glen Balch, Christopher Willett, Brian Czito

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Concurrent radiation therapy and chemotherapy is the primary treatment for patients with squamous cell tumors of the anal canal, and is also employed in the neoadjuvant setting for patients with stage II and III adenocarcinoma of the rectum. There is constant clinical study involving modifications of chemoradiotherapy regimens in an effort to maximize tumor responses while reducing normal tissue toxicity. This review will discuss established regimens as well as newer and novel treatment approaches to treatment of anal and rectal cancer.

Original languageEnglish (US)
Pages (from-to)177-185
Number of pages9
JournalCurrent Oncology Reports
Volume13
Issue number3
DOIs
StatePublished - Jun 2011

Fingerprint

Combined Modality Therapy
Carcinoma
Anus Neoplasms
Anal Canal
Chemoradiotherapy
Rectal Neoplasms
Rectum
Neoplasms
Adenocarcinoma
Radiotherapy
Therapeutics
Epithelial Cells
Drug Therapy

Keywords

  • Anal cancer
  • Chemotherapy
  • Combined modality
  • Radiation
  • Rectal cancer

ASJC Scopus subject areas

  • Oncology

Cite this

Update on treatment advances in combined-modality therapy for anal and rectal carcinomas. / Meyer, Jeffrey; Balch, Glen; Willett, Christopher; Czito, Brian.

In: Current Oncology Reports, Vol. 13, No. 3, 06.2011, p. 177-185.

Research output: Contribution to journalArticle

Meyer, Jeffrey ; Balch, Glen ; Willett, Christopher ; Czito, Brian. / Update on treatment advances in combined-modality therapy for anal and rectal carcinomas. In: Current Oncology Reports. 2011 ; Vol. 13, No. 3. pp. 177-185.
@article{00ae07d32133492ca02ec5ef4a1a91f7,
title = "Update on treatment advances in combined-modality therapy for anal and rectal carcinomas",
abstract = "Concurrent radiation therapy and chemotherapy is the primary treatment for patients with squamous cell tumors of the anal canal, and is also employed in the neoadjuvant setting for patients with stage II and III adenocarcinoma of the rectum. There is constant clinical study involving modifications of chemoradiotherapy regimens in an effort to maximize tumor responses while reducing normal tissue toxicity. This review will discuss established regimens as well as newer and novel treatment approaches to treatment of anal and rectal cancer.",
keywords = "Anal cancer, Chemotherapy, Combined modality, Radiation, Rectal cancer",
author = "Jeffrey Meyer and Glen Balch and Christopher Willett and Brian Czito",
year = "2011",
month = "6",
doi = "10.1007/s11912-011-0166-z",
language = "English (US)",
volume = "13",
pages = "177--185",
journal = "Current Oncology Reports",
issn = "1523-3790",
publisher = "Current Science, Inc.",
number = "3",

}

TY - JOUR

T1 - Update on treatment advances in combined-modality therapy for anal and rectal carcinomas

AU - Meyer, Jeffrey

AU - Balch, Glen

AU - Willett, Christopher

AU - Czito, Brian

PY - 2011/6

Y1 - 2011/6

N2 - Concurrent radiation therapy and chemotherapy is the primary treatment for patients with squamous cell tumors of the anal canal, and is also employed in the neoadjuvant setting for patients with stage II and III adenocarcinoma of the rectum. There is constant clinical study involving modifications of chemoradiotherapy regimens in an effort to maximize tumor responses while reducing normal tissue toxicity. This review will discuss established regimens as well as newer and novel treatment approaches to treatment of anal and rectal cancer.

AB - Concurrent radiation therapy and chemotherapy is the primary treatment for patients with squamous cell tumors of the anal canal, and is also employed in the neoadjuvant setting for patients with stage II and III adenocarcinoma of the rectum. There is constant clinical study involving modifications of chemoradiotherapy regimens in an effort to maximize tumor responses while reducing normal tissue toxicity. This review will discuss established regimens as well as newer and novel treatment approaches to treatment of anal and rectal cancer.

KW - Anal cancer

KW - Chemotherapy

KW - Combined modality

KW - Radiation

KW - Rectal cancer

UR - http://www.scopus.com/inward/record.url?scp=79955908063&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79955908063&partnerID=8YFLogxK

U2 - 10.1007/s11912-011-0166-z

DO - 10.1007/s11912-011-0166-z

M3 - Article

C2 - 21465120

AN - SCOPUS:79955908063

VL - 13

SP - 177

EP - 185

JO - Current Oncology Reports

JF - Current Oncology Reports

SN - 1523-3790

IS - 3

ER -